The CEO of Immune Bio (INMB), Dr. Raymond Tesi, says that the company has a drug candidate for Alzheimer which focuses on it being an immunological disease versus a neurological one.
The Watch List
08 Feb 2021
SHARE
The Watch List
18 Nov 2021
The Watch List
04 Jan 2022
The Watch List
20 Dec 2021
The Watch List
02 Dec 2021
The Watch List
09 Dec 2021
Trading 360
18 Jan 2022